We are live on
!
Find out more
Anika Therapeutics
ANIK
ANIK
139 hedge funds and large institutions have $568M invested in Anika Therapeutics in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 46 increasing their positions, 49 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
5% more capital invested
Capital invested by funds: $542M → $568M (+$26.2M)
6% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 49
1.56% less ownership
Funds ownership: 92.89% → 91.33% (-1.6%)
5% less funds holding
Funds holding: 146 → 139 (-7)
24% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 21
Holders
139
Holders Change
-7
Holders Change %
-4.79%
% of All Funds
2.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
46
Reduced
49
Closed
21
Calls
$315K
Puts
–
Net Calls
+$315K
Net Calls Change
-$19.8M
Top Buyers
Top Sellers
| 1 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
-$15.3M |
| 2 |
Natixis Advisors
Boston,
Massachusetts
|
-$7.33M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
-$4.79M |
| 4 |
Morgan Stanley
New York
|
-$3.81M |
| 5 |
Millennium Management
New York
|
-$3.36M |
